| Date | Title | Description |
| 09.04.2024 | Kryptos Biotechnologies: Illuminating the Path to Faster Diagnostics | Kryptos Biotechnologies, a rising star in the biotech world, recently secured $10 million in Series A funding to propel their innovative molecular diagnostics system towards FDA approval by 2025. Led by CEO Jinyong Lee, this Hayward-based c... |
| 04.04.2024 | OSANG Introduces COVID-19/Flu Combo Testing: FDA Emergency Use Authorizations Approved for POC and OTC | OSANG Healthcare US - Diagnostics designed to enhance your every da
COVID-19/Flu Combo Test.
PASADENA, CA, USA, April 4, 2024 /EINPresswire.com/ -- OSANG Healthcare, a leading healthcare diagnostics company since 1996, has announced its Eme... |
| 04.04.2024 | Kryptos Raises $10 Million in Series A Financing for Clinical Studies & FDA Approval for Molecular Diagnostics System | Kryptos Biotechnologies, Inc. - Diagnostic Solutions That Benefit Society
Strategic Investor, Osang Healthcare will partner with Kryptos Biotechnologies for the manufacturing and distribution of the product along with financing.
HAYWARD, CA... |
